Informed consent in research is the process of making sure anyone who volunteers for a study fully understands what they’re agreeing to before they participate. It’s not just a form to sign. It’s a three-part process built on disclosure (giving you the relevant information), comprehension (making sure you actually understand it), and voluntariness (confirming that no one is pressuring you into participating). Every federally funded or regulated study in the United States is required to follow this process.
Where the Requirement Comes From
The concept of informed consent in research has roots in some of the darkest chapters of medical history. After Nazi doctors conducted brutal experiments on concentration camp prisoners during World War II, the resulting Nuremberg Code established as its very first principle that “the voluntary consent of the human subject is absolutely essential.” That 1947 document became the foundation for every modern research ethics framework.
In 1979, the U.S. government published the Belmont Report, which laid out three core ethical principles for human subjects research: respect for persons, beneficence, and justice. Respect for persons is the principle most directly tied to informed consent. It holds two convictions: that individuals should be treated as autonomous agents capable of making their own decisions, and that people with diminished autonomy (such as children or individuals with cognitive impairments) deserve additional protection. The Belmont Report’s framework was eventually codified into federal regulations known as the Common Rule, which governs research at institutions across the country.
What a Consent Form Must Include
Federal regulations spell out eight required elements that every informed consent document must cover. These aren’t suggestions. They are legal requirements for any study regulated by agencies like the FDA or funded by the federal government.
- What the study involves. A clear statement that the project is research, what its purpose is, how long participation will last, what procedures you’ll go through, and which of those procedures are experimental.
- Risks. A description of any reasonably foreseeable risks or discomforts you might experience.
- Benefits. What you or others might gain from the research.
- Alternatives. Other options available to you, particularly if the research involves a medical treatment.
- Confidentiality. How your personal records will be protected, including a note that regulatory agencies like the FDA may have the right to inspect those records.
- Compensation for injury. For studies involving more than minimal risk, an explanation of whether any compensation or medical treatment is available if something goes wrong.
- Contact information. Who to call if you have questions about the research, your rights as a participant, or if you’re injured.
- Voluntary participation. A statement that you can refuse to participate or quit at any time without losing any benefits you’re otherwise entitled to and without any penalty.
Beyond these basics, researchers may also need to disclose additional details depending on the study: unforeseeable risks (including risks to a pregnancy), any extra costs you might face, what happens if the researchers end your participation early, and roughly how many people are enrolled. If significant new findings emerge during the study that might change your mind about staying in, the research team is required to share them with you.
It’s a Conversation, Not Just Paperwork
One of the most common misconceptions is that informed consent happens the moment you sign a piece of paper. In practice, consent is an ongoing conversation. The research team is responsible not only for providing information but for making sure you genuinely understand it. That distinction matters, because consent forms are notoriously difficult to read. Although experts recommend writing them at a sixth to eighth grade reading level, most consent documents land well above that, packed with technical language that can obscure what a participant is actually agreeing to.
Good consent processes use plain language, give you time to ask questions, and check your understanding rather than simply handing over a document. Some studies now use electronic consent (eConsent), which can incorporate videos, interactive quizzes, and multimedia explanations to help participants absorb the information at their own pace.
Your Right to Withdraw
Agreeing to participate never locks you in. You can withdraw from a study at any time, for any reason, without penalty. Once you withdraw, the research team must stop all research activities involving you: no more interventions, no collecting new data about you, no observing your private behavior.
What happens to data already collected is a bit more nuanced. Under federal regulations, researchers are generally permitted to keep and analyze data they gathered before you withdrew, as long as that analysis was part of the original study plan approved by an ethics review board. However, if the study isn’t regulated by the FDA, researchers can choose to honor a request to destroy your data or exclude it from analysis. If you withdraw only from the main intervention (say, you stop taking an experimental medication) but are willing to continue with follow-up surveys, the research team can continue those other components with your agreement.
Extra Protections for Vulnerable Groups
Standard informed consent assumes the participant is an adult who can weigh the information and freely decide. When that assumption doesn’t hold, additional safeguards kick in.
For children, researchers typically need both permission from a parent and assent from the child. Assent means the child agrees to participate in a way that’s appropriate for their age and maturity, even though they can’t legally consent. Research that poses more than minimal risk to children is only permitted under specific, tightly regulated conditions, and when children are wards of the state, an independent advocate must be appointed on their behalf.
Prisoners receive extra protections because the inherent power dynamics of incarceration make truly voluntary decisions difficult. Any study involving prisoners must go through additional layers of review, and the institution must receive written approval from federal oversight bodies before the research can begin. For individuals with diminished decision-making capacity, such as those with advanced dementia or certain psychiatric conditions, researchers must outline specific procedures for how consent will be obtained, often involving a legally authorized representative.
When Consent Can Be Waived
In limited circumstances, an Institutional Review Board (IRB), the ethics committee that oversees research at universities and hospitals, can waive or alter the standard consent requirements. This doesn’t happen casually. The IRB must document that the research poses no more than minimal risk and that the study simply couldn’t be carried out if consent were required. For example, a study analyzing anonymized hospital records might be impractical if researchers had to track down and obtain consent from every patient whose chart they reviewed.
Waivers can also apply when requiring consent would introduce bias that undermines the study’s validity, when the consent process itself would create privacy threats that otherwise wouldn’t exist, or when contacting individuals could cause psychological or social harm. In cases where participants weren’t told the full nature of the study upfront, the IRB may require that researchers debrief them afterward, sharing previously undisclosed information once their participation is complete.
A separate category of waivers applies to government-run studies evaluating public benefit programs, where officials may need to study how services are delivered or how payment methods could change. Even in these cases, the IRB must confirm the research couldn’t reasonably proceed without the waiver.